Oscar Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated February 10, 2022, reports the financial results for Oscar Health, Inc. for the fourth quarter and full year ended December 31, 2021. The filing incorporates by reference a press release (Exhibit 99.1) and an earnings presentation (Exhibit 99.2) containing the detailed operational and financial data.
Key Financial Metrics
The provided text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release and earnings presentation referenced in Items 2.02 and 7.01.
Material Changes
The filing text does not provide specific comparative data or material changes versus prior periods. Investors must refer to the attached exhibits for year-over-year or quarter-over-quarter performance analysis.
Guidance, Outlook, and Other Events
- Regulation FD Disclosure: The company posted an earnings presentation on its Investor Relations website.
- Annual Meeting: The 2022 Annual Meeting of Stockholders is scheduled for Thursday, June 9, 2022. The meeting will be held virtually.
- Legal Disclaimer: Information in Items 2.02 and 7.01 and the associated exhibits is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2021 revenue and loss figures.
- Examine Exhibit 99.2 (Earnings Presentation) for updated membership growth, medical loss ratios, and cash position.
- Verify the virtual meeting login procedures and voting instructions in the upcoming definitive proxy statement for the June 9, 2022 Annual Meeting.
- Confirm the company's status as an emerging growth company and any related accounting election impacts.